O	0	10	Protective	Protective	JJ	B-NP
O	11	19	function	function	NN	I-NP
O	20	22	of	of	IN	B-PP
O	23	26	von	von	NNP	B-NP
O	27	33	Hippel	Hippel	NNP	I-NP
O	33	34	-	-	HYPH	B-NP
O	34	40	Lindau	Lindau	NNP	I-NP
O	41	48	protein	protein	NN	I-NP
O	49	56	against	against	IN	B-PP
O	57	65	impaired	impaired	JJ	B-NP
O	66	73	protein	protein	NN	I-NP
O	74	84	processing	processing	NN	I-NP
O	85	87	in	in	IN	B-PP
B-Cell	88	93	renal	renal	JJ	B-NP
I-Cell	94	103	carcinoma	carcinoma	NN	I-NP
I-Cell	104	109	cells	cell	NNS	I-NP
O	109	110	.	.	.	O

O	111	114	The	The	DT	B-NP
O	115	122	absence	absence	NN	I-NP
O	123	125	of	of	IN	B-PP
O	126	136	functional	functional	JJ	B-NP
O	137	140	von	von	NNP	I-NP
O	141	147	Hippel	Hippel	NNP	I-NP
O	147	148	-	-	HYPH	I-NP
O	148	154	Lindau	Lindau	NNP	I-NP
O	155	156	(	(	(	O
O	156	159	VHL	VHL	NNP	O
O	159	160	)	)	)	O
B-Cancer	161	166	tumor	tumor	NN	B-NP
O	167	177	suppressor	suppressor	NN	I-NP
O	178	182	gene	gene	NN	I-NP
O	183	188	leads	lead	VBZ	B-VP
O	189	191	to	to	TO	B-PP
O	192	195	the	the	DT	B-NP
O	196	207	development	development	NN	I-NP
O	208	210	of	of	IN	B-PP
O	211	221	neoplasias	neoplasia	NNS	B-NP
O	222	236	characteristic	characteristic	JJ	B-ADJP
O	237	239	of	of	IN	B-PP
O	240	243	VHL	VHL	NN	B-NP
O	244	251	disease	disease	NN	I-NP
O	251	252	,	,	,	O
O	253	262	including	include	VBG	B-PP
B-Cancer	263	268	renal	renal	JJ	B-NP
I-Cancer	269	273	cell	cell	NN	I-NP
I-Cancer	274	283	carcinoma	carcinoma	NN	I-NP
O	284	285	(	(	(	O
B-Cancer	285	288	RCC	RCC	NN	B-NP
O	288	289	)	)	)	O
O	289	290	.	.	.	O

O	291	295	Here	Here	RB	B-ADVP
O	295	296	,	,	,	O
O	297	299	we	we	PRP	B-NP
O	300	308	compared	compare	VBD	B-VP
O	309	312	the	the	DT	B-NP
O	313	324	sensitivity	sensitivity	NN	I-NP
O	325	327	of	of	IN	B-PP
B-Cell	328	331	RCC	RCC	NN	B-NP
I-Cell	332	337	cells	cell	NNS	I-NP
O	338	345	lacking	lack	VBG	B-VP
O	346	349	VHL	VHL	NN	B-NP
O	350	354	gene	gene	NN	I-NP
O	355	363	function	function	NN	I-NP
O	364	368	with	with	IN	B-PP
O	369	373	that	that	DT	B-NP
O	374	376	of	of	IN	B-PP
B-Cell	377	380	RCC	RCC	NN	B-NP
I-Cell	381	386	cells	cell	NNS	I-NP
O	387	397	expressing	express	VBG	B-VP
O	398	401	the	the	DT	B-NP
O	402	406	wild	wild	JJ	I-NP
O	406	407	-	-	HYPH	I-NP
O	407	411	type	type	NN	I-NP
O	412	415	VHL	VHL	NN	I-NP
O	416	420	gene	gene	NN	I-NP
O	421	422	(	(	(	O
O	422	427	wtVHL	wtVHL	NN	B-NP
O	427	428	)	)	)	O
O	429	434	after	after	IN	B-PP
O	435	443	exposure	exposure	NN	B-NP
O	444	446	to	to	TO	B-PP
O	447	454	various	various	JJ	B-NP
O	455	463	stresses	stress	NNS	I-NP
O	463	464	.	.	.	O

O	465	470	While	While	IN	B-SBAR
O	471	474	the	the	DT	B-NP
O	475	483	response	response	NN	I-NP
O	484	486	to	to	TO	B-PP
O	487	491	most	most	JJS	B-NP
O	492	502	treatments	treatment	NNS	I-NP
O	503	506	was	be	VBD	B-VP
O	507	510	not	not	RB	I-VP
O	511	519	affected	affect	VBN	I-VP
O	520	522	by	by	IN	B-PP
O	523	526	the	the	DT	B-NP
O	527	530	VHL	VHL	NN	I-NP
O	531	535	gene	gene	NN	I-NP
O	536	542	status	status	NN	I-NP
O	542	543	,	,	,	O
O	544	551	glucose	glucose	NN	B-NP
O	552	563	deprivation	deprivation	NN	I-NP
O	564	567	was	be	VBD	B-VP
O	568	573	found	find	VBN	I-VP
O	574	576	to	to	TO	I-VP
O	577	579	be	be	VB	I-VP
O	580	584	much	much	RB	B-ADJP
O	585	589	more	more	RBR	I-ADJP
O	590	599	cytotoxic	cytotoxic	JJ	I-ADJP
O	600	603	for	for	IN	B-PP
B-Cell	604	607	RCC	RCC	NN	B-NP
I-Cell	608	613	cells	cell	NNS	I-NP
O	614	621	lacking	lack	VBG	B-VP
O	622	625	VHL	VHL	NN	B-NP
O	626	630	gene	gene	NN	I-NP
O	631	639	function	function	NN	I-NP
O	640	644	than	than	IN	B-PP
O	645	648	for	for	IN	B-PP
O	649	654	wtVHL	wtVHL	NN	B-NP
O	654	655	-	-	HYPH	O
O	655	665	expressing	express	VBG	B-VP
B-Cell	666	671	cells	cell	NNS	B-NP
O	671	672	.	.	.	O

O	673	676	The	The	DT	B-NP
O	677	687	heightened	heighten	VBN	I-NP
O	688	699	sensitivity	sensitivity	NN	I-NP
O	700	702	of	of	IN	B-PP
O	703	706	VHL	VHL	NN	B-NP
O	706	707	-	-	HYPH	B-NP
O	707	716	deficient	deficient	JJ	I-NP
B-Cell	717	722	cells	cell	NNS	I-NP
O	723	726	was	be	VBD	B-VP
O	727	730	not	not	RB	I-VP
O	731	741	attributed	attribute	VBN	I-VP
O	742	744	to	to	TO	B-PP
O	745	755	dissimilar	dissimilar	JJ	B-NP
O	756	762	energy	energy	NN	I-NP
O	763	775	requirements	requirement	NNS	I-NP
O	776	778	or	or	CC	B-PP
O	779	781	to	to	TO	B-PP
O	782	793	differences	difference	NNS	B-NP
O	794	796	in	in	IN	B-PP
O	797	804	glucose	glucose	NN	B-NP
O	805	811	uptake	uptake	NN	I-NP
O	811	812	,	,	,	O
O	813	816	but	but	CC	O
O	817	821	more	more	RBR	B-ADVP
O	822	828	likely	likely	RB	I-ADVP
O	829	837	reflects	reflect	VBZ	B-VP
O	838	839	a	a	DT	B-NP
O	840	846	lesser	less	JJR	I-NP
O	847	854	ability	ability	NN	I-NP
O	855	857	of	of	IN	B-PP
O	858	861	VHL	VHL	NN	B-NP
O	861	862	-	-	HYPH	B-NP
O	862	871	deficient	deficient	JJ	I-NP
B-Cell	872	877	cells	cell	NNS	I-NP
O	878	880	to	to	TO	B-VP
O	881	887	handle	handle	VB	I-VP
O	888	898	abnormally	abnormally	RB	B-NP
O	899	908	processed	process	VBN	I-NP
O	909	917	proteins	protein	NNS	I-NP
O	918	925	arising	arise	VBG	B-VP
O	926	930	from	from	IN	B-PP
O	931	939	impaired	impaired	JJ	B-NP
O	940	953	glycosylation	glycosylation	NN	I-NP
O	953	954	.	.	.	O

O	955	957	In	In	IN	B-PP
O	958	965	support	support	NN	B-NP
O	966	968	of	of	IN	B-PP
O	969	973	this	this	DT	B-NP
O	974	984	hypothesis	hypothesis	NN	I-NP
O	984	985	,	,	,	O
O	986	991	other	other	JJ	B-NP
O	992	1002	treatments	treatment	NNS	I-NP
O	1003	1008	which	which	WDT	B-NP
O	1009	1012	act	act	VBP	B-VP
O	1013	1020	through	through	IN	B-PP
O	1021	1030	different	different	JJ	B-NP
O	1031	1041	mechanisms	mechanism	NNS	I-NP
O	1042	1044	to	to	TO	B-VP
O	1045	1054	interfere	interfere	VB	I-VP
O	1055	1059	with	with	IN	B-PP
O	1060	1067	protein	protein	NN	B-NP
O	1068	1078	processing	processing	NN	I-NP
O	1079	1080	(	(	(	O
O	1080	1081	i	i	NN	B-NP
O	1081	1082	.	.	.	O
O	1082	1083	e	e	NN	B-NP
O	1083	1084	.	.	NN	I-NP
O	1084	1085	,	,	,	O
O	1086	1097	tunicamycin	tunicamycin	NN	B-NP
O	1097	1098	,	,	,	O
O	1099	1108	brefeldin	brefeldin	NN	B-NP
O	1109	1110	A	A	NN	I-NP
O	1110	1111	,	,	,	O
O	1112	1115	and	and	CC	O
O	1116	1125	azetidine	azetidine	NN	B-NP
O	1125	1126	)	)	)	O
O	1127	1131	were	be	VBD	B-VP
O	1132	1136	also	also	RB	I-VP
O	1137	1142	found	find	VBN	I-VP
O	1143	1145	to	to	TO	I-VP
O	1146	1148	be	be	VB	I-VP
O	1149	1153	much	much	RB	B-ADJP
O	1154	1158	more	more	RBR	I-ADJP
O	1159	1164	toxic	toxic	JJ	I-ADJP
O	1165	1168	for	for	IN	B-PP
O	1169	1172	VHL	VHL	NN	B-NP
O	1172	1173	-	-	HYPH	I-NP
O	1173	1182	deficient	deficient	JJ	I-NP
B-Cell	1183	1188	cells	cell	NNS	I-NP
O	1188	1189	.	.	.	O

O	1190	1201	Furthermore	Furthermore	RB	B-ADVP
O	1201	1202	,	,	,	O
O	1203	1217	ubiquitination	ubiquitination	NN	B-NP
O	1218	1220	of	of	IN	B-PP
B-Cell	1221	1229	cellular	cellular	JJ	B-NP
O	1230	1238	proteins	protein	NNS	I-NP
O	1239	1242	was	be	VBD	B-VP
O	1243	1251	elevated	elevate	VBN	I-VP
O	1252	1254	in	in	IN	B-PP
O	1255	1258	VHL	VHL	NN	B-NP
O	1258	1259	-	-	HYPH	B-NP
O	1259	1268	deficient	deficient	JJ	I-NP
B-Cell	1269	1274	cells	cell	NNS	I-NP
O	1274	1275	,	,	,	O
O	1276	1288	particularly	particularly	RB	B-ADVP
O	1289	1294	after	after	IN	B-SBAR
O	1295	1302	glucose	glucose	NN	B-NP
O	1303	1314	deprivation	deprivation	NN	I-NP
O	1314	1315	,	,	,	O
O	1316	1326	supporting	support	VBG	B-VP
O	1327	1328	a	a	DT	B-NP
O	1329	1333	role	role	NN	I-NP
O	1334	1337	for	for	IN	B-PP
O	1338	1341	the	the	DT	B-NP
O	1342	1345	VHL	VHL	NN	I-NP
O	1346	1350	gene	gene	NN	I-NP
O	1351	1353	in	in	IN	B-PP
O	1354	1363	ubiquitin	ubiquitin	NN	B-NP
O	1363	1364	-	-	HYPH	B-NP
O	1364	1372	mediated	mediate	VBN	I-NP
O	1373	1384	proteolysis	proteolysis	NN	I-NP
O	1384	1385	.	.	.	O

O	1386	1397	Accordingly	Accordingly	RB	B-ADVP
O	1397	1398	,	,	,	O
O	1399	1402	the	the	DT	B-NP
O	1403	1407	rate	rate	NN	I-NP
O	1408	1410	of	of	IN	B-PP
O	1411	1422	elimination	elimination	NN	B-NP
O	1423	1425	of	of	IN	B-PP
O	1426	1434	abnormal	abnormal	JJ	B-NP
O	1435	1443	proteins	protein	NNS	I-NP
O	1444	1447	was	be	VBD	B-VP
O	1448	1453	lower	low	JJR	B-ADJP
O	1454	1456	in	in	IN	B-PP
B-Cell	1457	1462	cells	cell	NNS	B-NP
O	1463	1470	lacking	lack	VBG	B-VP
O	1471	1472	a	a	DT	B-NP
O	1473	1483	functional	functional	JJ	I-NP
O	1484	1487	VHL	VHL	NN	I-NP
O	1488	1492	gene	gene	NN	I-NP
O	1493	1497	than	than	IN	B-PP
O	1498	1500	in	in	IN	B-PP
O	1501	1506	wtVHL	wtVHL	NN	B-NP
O	1506	1507	-	-	HYPH	O
O	1507	1517	expressing	express	VBG	B-VP
B-Cell	1518	1523	cells	cell	NNS	B-NP
O	1523	1524	.	.	.	O

O	1525	1529	Thus	Thus	RB	B-ADVP
O	1529	1530	,	,	,	O
O	1531	1535	pVHL	pVHL	NN	B-NP
O	1536	1543	appears	appear	VBZ	B-VP
O	1544	1546	to	to	TO	I-VP
O	1547	1558	participate	participate	VB	I-VP
O	1559	1561	in	in	IN	B-PP
O	1562	1565	the	the	DT	B-NP
O	1566	1577	elimination	elimination	NN	I-NP
O	1578	1580	of	of	IN	B-PP
O	1581	1593	misprocessed	misprocesse	VBN	B-NP
O	1594	1602	proteins	protein	NNS	I-NP
O	1602	1603	,	,	,	O
O	1604	1608	such	such	JJ	B-PP
O	1609	1611	as	as	IN	I-PP
O	1612	1617	those	those	DT	B-NP
O	1618	1625	arising	arise	VBG	B-VP
O	1626	1628	in	in	IN	B-PP
O	1629	1632	the	the	DT	B-NP
B-Cell	1633	1637	cell	cell	NN	I-NP
O	1638	1641	due	due	JJ	B-ADJP
O	1642	1644	to	to	TO	B-PP
O	1645	1648	the	the	DT	B-NP
O	1649	1663	unavailability	unavailability	NN	I-NP
O	1664	1666	of	of	IN	B-PP
O	1667	1674	glucose	glucose	NN	B-NP
O	1675	1677	or	or	CC	B-PP
O	1678	1680	to	to	TO	B-PP
O	1681	1686	other	other	JJ	B-NP
O	1687	1695	stresses	stress	NNS	I-NP
O	1695	1696	.	.	.	O

